ASX · CSL.AX
CSL Limited
A$200.73+A$3.23 (+1.64%)
CSL Limited’s quoted price sits in the upper half of its reported 52-week range, 0.69% below the high.
Loading market information…
ASX · RNV.AX · AUD
Stock price
Quote as of Oct 28, 2026, 04:43 AM UTC. Cached market data; not a live quote.
One-year closing-price history · AUD. Historical prices are not a forecast.
ReNerve Limited’s quoted price sits in the lower half of its reported 52-week range, 59.09% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
ReNerve Limited, a medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures in New Zealand and the United States. It develops Nerve Cuff, a bioabsorbable protective wrap used to protect repaired nerves; and Nerve Graft, an off-the-shelf nerve grafts for the repair of damaged nerves under the NervAlign brand. The company also offers dermal tissue product, a deep dermal product used in the repair of reconstructive and cosmetic surgical cases; and amniotic tissue product ranges used to aid the healing of wounds under the Empliq brand. In addition, it provides Nerve Conduit Range, a nerve conduit designed to facilitate nerve growth over short gaps between nerve ends; bionic nerve, a novel combination polymer technology; and Nerve Guide Matrix for treating more severe nerve injuries, but eliminating the need for patients to undergo additional sural nerve harvesting under the NervAlign brand that are in development phase. The company was incorporated in 2016 and is headquartered in Northcote, Australia.
Latest available per-share figures in AUD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:45 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
A$200.73+A$3.23 (+1.64%)
CSL Limited’s quoted price sits in the upper half of its reported 52-week range, 0.69% below the high.
A$2.73+A$0.01 (+0.37%)
Sigma Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 14.69% below the high.
A$196.20-A$0.89 (-0.45%)
Pro Medicus Limited’s quoted price sits in the upper half of its reported 52-week range, 28.09% below the high.
A$55.60+A$0.68 (+1.24%)
Ramsay Health Care Limited’s quoted price sits in the upper half of its reported 52-week range, 0.89% below the high.
A$19.57+A$0.50 (+2.62%)
Sonic Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 19.37% below the high.
A$143.64+A$1.44 (+1.01%)
Cochlear Limited’s quoted price sits in the lower half of its reported 52-week range, 50.67% below the high.
A$45.44+A$0.32 (+0.71%)
Ansell Limited’s quoted price sits in the upper half of its reported 52-week range, 2.84% below the high.
A$13.13-A$0.35 (-2.6%)
Telix Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 27.94% below the high.
